Cancer Drug Resistance

作者应在稿件中披露任何人工智能及AI辅助技术的使用情况；AI生成的文本和参考文献须仔细核查以确保准确；如未涉及AI使用，应在该部分注明“Not applicable”。 模型中文摘要

Authors should disclose in their manuscript any use of AI and AI-assisted technologies. Declaring the use of these technologies supports transparency and trust between authors, readers, reviewers, editors, and contributors, and facilitates compliance with the terms of use of the relevant tool or technology.AI-generated text and references should be carefully checked to ensure accuracy and that the…

作者署名资格仅基于对已发表研究的实质性贡献，须满足四项标准：对研究构思设计或数据获取、分析、解释作出实质性贡献；撰写初稿或对内容进行重要学术修改；对最终发表版本进行最终批准；同意对工作的所有方面负责并确保相关问题得到妥善调查。 模型中文摘要

Authorship credit of CDR journals should be solely based on substantial contributions to a published study, as specified in the following four criteria:1. Substantial contributions to the conception or design of the work, or the acquisition, analysis, or interpretation of data for the work;2. Drafting the work or revising it critically for important intellectual content;3. Final approval of the ve…

作者必须申报任何可能被视为不当影响研究结果表述或解释的潜在利益冲突；如无利益冲突，应声明“所有作者声明不存在利益冲突”；受保密协议约束的作者应声明因保密协议无法披露利益冲突。 模型中文摘要

Authors must declare any potential conflicts of interest that may be perceived as inappropriately influencing the representation or interpretation of reported research results. If there are no conflicts of interest, please state "All authors declared that there are no conflicts of interest." in this section. Some authors may be bound by confidentiality agreements. In such cases, in place of itemiz…

为维护研究记录的完整性、透明度和可重复性，作者应在稿件中说明支持其研究结论的数据存放位置；数据可存入数据存储库或作为期刊补充信息发表；无法共享数据的作者应说明数据不予共享并解释原因；如不涉及此问题，应注明“Not applicable”。 模型中文摘要

In order to maintain the integrity, transparency and reproducibility of research records, authors should include this section in their manuscripts, detailing where the data supporting their findings can be found. Data can be deposited into data repositories or published as supplementary information in the journal. Authors who cannot share their data should state that the data will not be shared an…

涉及人类受试者、人体材料或人类数据的研究必须符合《赫尔辛基宣言》并经适当伦理委员会批准；应获得参与者或其父母/法定监护人（16岁以下儿童）的知情同意；稿件中必须写明伦理委员会名称（含参考编号）及所获知情同意；涉及动物和细胞系的研究必须包含伦理声明。 模型中文摘要

Research involving human subjects, human material or human data must be performed in accordance with the Declaration of Helsinki and approved by an appropriate ethics committee. An informed consent to participate in the study should also be obtained from participants, or their parents or legal guardians for children under 16. A statement detailing the name of the ethics committee (including the re…

期刊采用金色开放获取出版模式，内容依据知识共享署名4.0国际许可协议发布，版权由作者保留。 模型中文摘要

The journal adopts Gold Open Access publishing model and distributes content under the Creative Commons Attribution 4.0 International License. Copyright is retained by authors. Please make sure that you are well aware of these policies.

期刊采用金色开放获取出版模式，内容依据知识共享署名4.0国际许可协议发布，版权由作者保留。 模型中文摘要

The journal adopts Gold Open Access publishing model and distributes content under the Creative Commons Attribution 4.0 International License. Copyright is retained by authors. Please make sure that you are well aware of these policies.

CDR要求作者对稿件中报告的所有相关临床试验进行注册，并遵循世界卫生组织对临床试验的定义，即前瞻性地将人类受试者分配至一项或多项健康相关干预以评估健康结局的研究。 模型中文摘要

CDR requires all authors to register all relevant clinical trials that are reported in manuscripts submitted. CDR follows the World Health Organization (WHO)'s definition of clinical trials: "A clinical trial is any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes. Interventions i…